Heritage Bio Labs
Research Library
Explore 411 articles about peptides, research compounds and related topics, with links to the original studies.
Find articles
Matching articles
Showing 49–60 of 77 articles · Interpret the evidence
- Interpret the evidence
What a tumor biomarker registry can tell us about MGF
The term MGF can refer to an insulin-like growth factor 1 splice form or to a synthetic peptide modeled on part of it. A human study registered in September 2025, before the recent publication window, uses MGF-related terminology in a question about blood markers and solid tumors.
MGF2 sources (2013, 2025)
- Interpret the evidence
Why turning on an energy signal did not improve cell repair in one study
MOTS-c is a peptide encoded in mitochondrial DNA. A 2026 study asked whether exposing human fat-derived stromal cells to MOTS-c could improve their ability to support repair in a mouse model of kidney injury.
MOTS-C1 source (2026)
- Interpret the evidence
What an early cough comparison reported after COVID-19
MSC exosomes are membrane-bound particles released by mesenchymal stromal cells. They are one category of extracellular vesicle and can contain several kinds of molecules. A 2026 pilot study examined a stromal cell extracellular vesicle preparation in people with persistent cough after COVID-19.
MSC Exosomes2 sources (2024, 2026)
- Interpret the evidence
What expanded access data can reveal about safety
MSC exosomes are a type of membrane-bound extracellular vesicle from mesenchymal stromal cells. A 2026 report studied an extracellular vesicle-enriched preparation in hospitalized people with respiratory failure due to COVID-19. It used expanded access observations to look at safety.
MSC Exosomes2 sources (2024, 2026)
- Interpret the evidence
Why an exosome study and an FDA approval are separate records
MSC exosomes are a type of extracellular vesicle released by mesenchymal stromal cells. They are particles with a membrane, rather than a single peptide. In a February 2026 warning letter, the FDA addressed the status of certain products marketed as exosomes for medical purposes.
MSC Exosomes3 sources (2020–2026)
- Interpret the evidence
How mouse muscle separated force from fatigue
Myostatin, also called GDF8, is a larger signaling protein with a recognized role in limiting muscle size. A 2026 study in mice asked whether muscle with higher myostatin expression also used energy differently and resisted fatigue during repeated contractions.
Myostatin1 source (2026)
- Interpret the evidence
What a 2026 Cesarean Delivery Study Compared About Blood Loss
Oxytocin stimulates uterine contractions, one reason it is studied and used in obstetric care. A 2026 clinical trial compared oxytocin with carbetocin, a related but distinct uterotonic, with or without a medicine called tranexamic acid.
Oxytocin2 sources (2026)
- Interpret the evidence
Why Oxytocin’s Pain Findings Depended on the Experimental Context
Oxytocin is one such peptide hormone, studied for possible effects on fear, stress and the experience of pain. A randomized 2026 study asked whether the response to an experimental painful stimulus changed depending on the emotional context.
Oxytocin1 source (2026)
- Interpret the evidence
What a Rat Navigation Study Can Tell Us About Pinealon and Learning
Pinealon, also called EDR, is a three-amino-acid peptide. An older study examined how young and old rats performed on a navigation task after exposure to Pinealon or a different preparation.
Pinealon1 source (2013)
- Interpret the evidence
Why the Bremelanotide Extension Study Cannot Replace a Placebo Comparison
PT-141, or bremelanotide, had a 52-week extension after the controlled phase of the RECONNECT studies. The older extension is the direct source for this comparison of study designs. Its results should be read alongside the current US labeling.
PT-1412 sources (2019, 2026)
- Interpret the evidence
Why glucose averages leave a combination safety question open
Retatrutide is an investigational peptide that activates GIP, GLP-1 and glucagon receptors. IGF-1 LR3 is a modified growth-factor protein with an extended amino-acid sequence.
RETA / IGF-1 LR33 sources (1997–2026)
- Interpret the evidence
What a different retatrutide combination taught researchers about study design
Retatrutide is an investigational GIP, GLP-1 and glucagon receptor agonist. IGF-1 LR3 is a modified, extended insulin-like growth factor protein. The exact pair in this entry is separate from a 2026 rat experiment that tested retatrutide with cagrilintide, an amylin-based peptide.
RETA / IGF-1 LR32 sources (1992, 2026)
Browse by product
- A4 Amyloid Beta6 articles
- ACE-0316 articles
- ACE-0836 articles
- Adipotide6 articles
- AICAR6 articles
- AOD-96046 articles
- ARA-2906 articles
- BPC-1576 articles
- BPC-157 / TB-5006 articles
- Cagrilintide7 articles
- CJC-1295 (No DAC) / GHRP-26 articles
- CJC-1295 (No DAC) / GHRP-66 articles
- CJC-1295 (No DAC) / Ipamorelin6 articles
- CJC-1295 No DAC6 articles
- CJC-1295 With DAC6 articles
- DSIP6 articles
- Epitalon6 articles
- Follistatin 3156 articles
- Follistatin 3446 articles
- Fragment 176-1916 articles
- GHK-Cu6 articles
- GHRP-26 articles
- GHRP-66 articles
- GLOW 2 Blend6 articles
- GLOW Blend6 articles
- GLP-1 SEMA6 articles
- GLP-2 TIRZ6 articles
- Glutathione6 articles
- HCG6 articles
- Hexarelin6 articles
- Human Relaxin-26 articles
- IGF-1 DES 1,36 articles
- IGF-1 Human6 articles
- IGF-2 LR36 articles
- IGF-DES 1,36 articles
- IGF-LR36 articles
- Ipamorelin6 articles
- Kisspeptin-106 articles
- KLOW Blend6 articles
- KPV6 articles
- Lipopeptide6 articles
- Liraglutide6 articles
- Melanotan II5 articles
- MGF6 articles
- MOTS-C6 articles
- MSC Exosomes6 articles
- Myostatin6 articles
- Myostatin HMP (GDF8)6 articles
- Oxytocin7 articles
- PEG-MGF6 articles
- Pinealon6 articles
- PT-1416 articles
- RETA / IGF-1 LR36 articles
- RETA GLP-36 articles
- Selank6 articles
- SEMA / IGF-1 LR36 articles
- Semax6 articles
- Sermorelin6 articles
- SLU-PP-3326 articles
- SNAP-86 articles
- Survodutide7 articles
- TB-5006 articles
- Tesamorelin6 articles
- Thymosin Alpha-16 articles
- TIRZ / IGF-1 LR36 articles
- TIRZ GLP-26 articles
- Trevogrumab6 articles
- Triptorelin GnRH6 articles
